Coya Therapeutics (NASDAQ:COYA) Earns Buy Rating from HC Wainwright
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at HC Wainwright in a research report issued to clients and investors on Monday,Benzinga reports. They presently have a $18.00 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 219.72% from the stock’s previous […]
